Shili Yang

Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain

Shanshan Liu, Shili Yang, Paul C. Ho · Asian Journal of Pharmaceutical Sciences · 2017 · 212 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

<i>In Vitro</i> and <i>In Vivo</i> Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic-<i>co</i>-glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes Administered Intranasally as Therapeutic Strategies for Alzheimer’s Disease

Li Zhang, Shili Yang, Ling Rong Wong et al. · Molecular Pharmaceutics · 2020 · 113 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease

Kai Chang, Hai Ning Pee, Shili Yang et al. · Scientific Reports · 2015 · 61 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Poly (ethylene glycol)-block-poly (D, L-lactide) (PEG-PLA) micelles for brain delivery of baicalein through nasal route for potential treatment of neurodegenerative diseases due to oxidative stress and inflammation: An in vitro and in vivo study

Zhang Li, Shili Yang, Lizhen Huang et al. · International Journal of Pharmaceutics · 2020 · 46 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer’s Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist

Kai Chang, Ling Rong Wong, Hai Ning Pee et al. · Molecular Neurobiology · 2019 · 35 citations

Life Sciences, Neuroscience, Pharmacology +17